GALECTIN THERAPEUTICS INC
GALT·363225202·US·Common Stock·Healthcare - Biotechnology
GALT (GALECTIN THERAPEUTICS INC) is held by 62 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($5.5M), MARSHALL WACE, LLP ($3.4M), OSAIC HOLDINGS, INC. ($3.1M). Net institutional sentiment: Mixed.
62
Holders
Avg rating(14 Elite)
$33.4M
Total Value
62% (68)
Fund Consensus
37 buying - 23 selling
Who's Trading
InsiderJKJamil KhurramSell $24KJun 23, 2026
InsiderJKJamil KhurramSell $2KMay 26, 2026
InsiderLJLEWIS JOELSell $135KJan 6, 2026
InsiderCWCALLICUTT JACK WSell $75KJan 6, 2026
InsiderJKJamil KhurramSell $78KJan 6, 2026
InsiderLJLEWIS JOELSell $108KJan 5, 2026
InsiderCWCALLICUTT JACK WSell $100KJan 5, 2026
InsiderJKJamil KhurramSell $99KJan 5, 2026
InsiderLJLEWIS JOELSell $78KJan 2, 2026
InsiderCWCALLICUTT JACK WSell $58KJan 2, 2026
13F: Insider & Congress:
Showing 1-20 of 68
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer